20:05 EDT Cathie Wood’s ARK Investment bought 90K shares of Crispr Therapeutics today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
- Crispr Therapeutics price target lowered to $95 from $102 at Oppenheimer
- CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
- Crispr Therapeutics price target lowered to $65 from $70 at Wells Fargo
- Crispr Therapeutics price target raised to $52 from $46 at Baird